Zoetis (ZOETI) Reports Q4 Earnings Up, Revenue Steady

Zoetis Inc. (ZOETI) reported fourth-quarter net income of $297 million, a 12% increase from $265 million in the same period of 2025, on revenue of $1.96 billion, essentially unchanged from the prior-year quarter. The improvement followed strong performance in its vaccine and biosurgery segments, with sales up 8% and 15%, respectively. Management attributed the results to higher pricing and improved demand for its core animal health products.